Literature DB >> 28351032

Baicalein, a Natural Anti-Cancer Compound, Alters MicroRNA Expression Profiles in Bel-7402 Human Hepatocellular Carcinoma Cells.

Beibei Bie1,2, Jin Sun1,2, Jun Li1,2, Ying Guo1,2, Wei Jiang1,2, Chen Huang2,3, Jun Yang1,2, Zongfang Li1,2,3.   

Abstract

BACKGROUND/AIMS: Baicalein has been shown to possess significant anti-hepatoma activity by inhibiting cell proliferation. Whether the anti-proliferative effect of baicalein is related to its modulation of miRNA expression in hepatocellular carcinoma (HCC) is still unknown.
METHODS: The anti-proliferative effects of baicalein on HCC cell line Bel-7402 was assessed by detecting the proliferation activity, cell cycle distribution, expression changes of p21/CDKN1A, P27/CDKN1B, total Akt and phosphoryted AKT. Microarray analysis was conducted to determine the miRNA expression profiles in baicalein-treated or untreated Bel-7402 cells and then validated by qRT-PCR in two HCC cell lines (Bel-7402 and Hep3B). The gain-of-function of miR-3127-5p was performed by detecting anti-proliferative effects after transfecting miRNA mimics in cells. Finally, the expression level of miR-3127-5p in different HCC cell lines was determined by qRT-PCR.
RESULTS: Baicalein was able to inhibit the proliferation of Bel-7402 cells by inducing cell cycle arrest at the S and G2/M phase via up-regulating the expression of p21/CDKN1A and P27/CDKN1B and suppressing the PI3K/Akt pathway. Baicalein could alter the miRNA expression profiles in Bel-7402 cells. Putative target genes for differentially expressed miRNAs could be enriched in terms of cell proliferation regulation, cell cycle arrest and were mainly involved in MAPK, PI3K-Akt, Wnt, Hippo and mTOR signaling pathways. MiR- 3127-5p, one of up-regulated miRNAs, exhibits low expression level in several HCC cell lines and its overexpression could inhibit cell growth of Bel-7402 and Hep3B cell lines by inducing S phase arrest by up-regulating the expression of p21and P27 and repressing the PI3K/Akt pathway.
CONCLUSIONS: Modulation of miRNA expression may be an important mechanism underlying the anti-hepatoma effects of baicalein.
© 2017 The Author(s)Published by S. Karger AG, Basel.

Entities:  

Keywords:  Anti-proliferative; Baicalein; Expression profiling; Hepatocellular carcinoma; MicroRNA

Mesh:

Substances:

Year:  2017        PMID: 28351032     DOI: 10.1159/000470815

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  18 in total

1.  Baicalein suppress EMT of breast cancer by mediating tumor-associated macrophages polarization.

Authors:  Xixi Zhao; Jingkun Qu; Xu Liu; Jizhao Wang; Xingcong Ma; Xiaoyao Zhao; Qian Yang; Wanjun Yan; Zitong Zhao; Yuxin Hui; Haocheng Bai; Shuqun Zhang
Journal:  Am J Cancer Res       Date:  2018-08-01       Impact factor: 6.166

Review 2.  Latest research progress on anticancer effect of baicalin and its aglycone baicalein.

Authors:  Lin Wang; Ting Feng; Zhilian Su; Chao Pi; Yumeng Wei; Ling Zhao
Journal:  Arch Pharm Res       Date:  2022-07-31       Impact factor: 6.010

3.  Emodin and baicalein inhibit sodium taurocholate-induced vacuole formation in pancreatic acinar cells.

Authors:  Jun Li; Rui Zhou; Bei-Bei Bie; Na Huang; Ying Guo; Hai-Yan Chen; Meng-Jiao Shi; Jun Yang; Jian Zhang; Zong-Fang Li
Journal:  World J Gastroenterol       Date:  2018-01-07       Impact factor: 5.742

4.  Baicalein attenuates OVA-induced allergic airway inflammation through the inhibition of the NF-κB signaling pathway.

Authors:  Tingting Xu; Xiangting Ge; Chun Lu; Wei Dai; Hongjin Chen; Zhongxiang Xiao; Liqin Wu; Guang Liang; Songmin Ying; Yali Zhang; Yuanrong Dai
Journal:  Aging (Albany NY)       Date:  2019-11-06       Impact factor: 5.682

Review 5.  Participation of MicroRNAs in the Treatment of Cancer with Phytochemicals.

Authors:  Seung Wan Son; Han Yeoung Lee; Sokviseth Moeng; Hyo Jeong Kuh; Soo Young Choi; Jong Kook Park
Journal:  Molecules       Date:  2020-10-14       Impact factor: 4.411

6.  Baicalein Represses Cervical Cancer Cell Growth, Cell Cycle Progression and Promotes Apoptosis via Blocking AKT/mTOR Pathway by the Regulation of circHIAT1/miR-19a-3p Axis.

Authors:  Jiaojiao Hu; Runkun Wang; Yi Liu; Jianbo Zhou; Ka Shen; Yun Dai
Journal:  Onco Targets Ther       Date:  2021-02-09       Impact factor: 4.147

Review 7.  MicroRNAs Regulating Hippo-YAP Signaling in Liver Cancer.

Authors:  Na-Hyun Lee; So Jung Kim; Jeongeun Hyun
Journal:  Biomedicines       Date:  2021-03-30

8.  Baicalein inhibits progression of osteosarcoma cells through inactivation of the Wnt/β-catenin signaling pathway.

Authors:  Guo Dai; Di Zheng; Qianliang Wang; Jian Yang; Gaiwei Liu; Qi Song; Xiangran Sun; Chunjie Tao; Qingzhu Hu; Tian Gao; Ling Yu; Weichun Guo
Journal:  Oncotarget       Date:  2017-09-18

9.  Baicalein inhibits cell growth and increases cisplatin sensitivity of A549 and H460 cells via miR-424-3p and targeting PTEN/PI3K/Akt pathway.

Authors:  Chunya Lu; Huaqi Wang; Shanshan Chen; Rui Yang; Hui Li; Guojun Zhang
Journal:  J Cell Mol Med       Date:  2018-02-01       Impact factor: 5.310

10.  The interaction between cucurbit[8]uril and baicalein and the effect on baicalein properties.

Authors:  Xiaodong Zhang; Jun Xie; Zhiling Xu; Zhu Tao; Qianjun Zhang
Journal:  Beilstein J Org Chem       Date:  2020-01-10       Impact factor: 2.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.